New year, new (higher) drug prices
Surging drug prices in the United States are a thorny yet key bipartisan issue as another presidential election beckons. While US President Trump struggles to make good on his promise to lower drug prices, the industry, which has long thrived in its laissez-faire ecosystem, has persistently argued that government intervention will stifle innovation. And now, as the new year kicks off, a cadre of drugmakers has quietly inflated prices on more than 250 drugs, according to a Reuters report.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.